Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Health Evaluation of Abilify Long-term Therapy

NCT00520650 is registered in ClinicalTrials.gov with Taiwan Otsuka Pharm. Co., Ltd as lead sponsor.

NCT NCT00520650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00520650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Health Evaluation of Abilify Long-term Therapy
Lead sponsor
Taiwan Otsuka Pharm. Co., Ltd
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2006
Completion date
April 30, 2009
Enrollment
245 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia